CYCLO THERAPEUTICS INC's ticker is CYTHW and the CUSIP is 23254X110. A total of 6 filers reported holding CYCLO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $140,542 | +36.4% | 270,274 | -7.9% | 0.05% | +43.8% |
| Q3 2022 | $103,000 | +171.1% | 293,531 | -0.3% | 0.03% | +220.0% |
| Q2 2022 | $38,000 | -95.9% | 294,431 | -0.2% | 0.01% | -95.6% |
| Q1 2022 | $935,000 | -15.0% | 294,931 | 0.0% | 0.23% | -31.6% |
| Q4 2021 | $1,100,000 | -39.2% | 294,931 | -15.7% | 0.34% | +3.1% |
| Q2 2021 | $1,808,000 | +18.7% | 350,000 | 0.0% | 0.32% | -47.5% |
| Q4 2020 | $1,523,000 | – | 350,000 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 63,036 | $87,000 | 0.41% |
| AIGH Capital Management LLC | 294,931 | $935,000 | 0.23% |
| Worth Venture Partners, LLC | 74,736 | $99,000 | 0.05% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Verition Fund Management LLC | 800,000 | $0 | 0.00% |
| UBS Group AG | 1,146 | $2,000 | 0.00% |